CCM
UTHR icon

Cinctive Capital Management’s United Therapeutics UTHR Stock Holding History

Cinctive Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86M Buy
6,515
+5,278
+427% +$2.63M 0.25% 136
2025
Q4 		$603K Sell
1,237
-6,270
-84% -$2.92M 0.03% 320
2025
Q3 		$3.15M Buy
+7,507
New +$2.52M 0.15% 204
2024
Q3 		– Sell
-5,762
Closed -$1.84M – 527
2024
Q2 		$1.84M Buy
5,762
+3,039
+112% +$804K 0.09% 260
2024
Q1 		$626K Sell
2,723
-2,559
-48% -$577K 0.03% 329
2023
Q4 		$1.16M Buy
+5,282
New +$1.22M 0.08% 239
2021
Q4 		– Sell
-27,362
Closed -$5.05M – 661
2021
Q3 		$5.05M Sell
27,362
-27,321
-50% -$5.38M 0.25% 132
2021
Q2 		$9.81M Sell
54,683
-7,598
-12% -$1.45M 0.46% 47
2021
Q1 		$10.4M Buy
62,281
+2,133
+4% +$356K 0.64% 27
2020
Q4 		$9.13M Buy
60,148
+4,395
+8% +$577K 0.74% 23
2020
Q3 		$5.63M Buy
55,753
+14,247
+34% +$1.56M 0.49% 61
2020
Q2 		$5.02M Sell
41,506
-3,970
-9% -$447K 0.58% 44
2020
Q1 		$4.31M Sell
45,476
-18,724
-29% -$1.78M 0.96% 25
2019
Q4 		$5.66M Buy
+64,200
New +$5.65M 0.59% 77

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cinctive Capital Management's UTHR Position: Q1 2026 in Review

Cinctive Capital Management increased its United Therapeutics (UTHR) stake by 427% in Q1 2026, buying an estimated $2.63M and bringing the position to 6,515 shares worth $3.86M. The position accounts for 0.25% of the portfolio, ranked #136.

Cinctive Capital Management first reported a position in UTHR in Q4 2019 and has held it in 14 quarters since. The position peaked at $10.4M in Q1 2021. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Cinctive Capital Management held 6,515 shares of United Therapeutics worth $3.86M as of Q1 2026.
  • Cinctive Capital Management bought 5,278 United Therapeutics shares in Q1 2026, an estimated $2.63M.
  • United Therapeutics made up 0.25% of Cinctive Capital Management's portfolio in Q1 2026, its #136 holding.
  • Cinctive Capital Management first reported a position in United Therapeutics in Q4 2019 and has held it in 14 quarters since.
  • Cinctive Capital Management's United Therapeutics position peaked at $10.4M in Q1 2021.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.